Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China
· Delayed Price · Currency is CNY 15.35
+0.03 (0.20%)
Dec 5, 2025, 3:00 PM CST
SHA:600535 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 2,603 | 2,994 | 4,451 | 3,119 | 2,304 | 1,976 | Upgrade
|
| Trading Asset Securities | 886.32 | 524.72 | 300.71 | 1,125 | 1,487 | 142.92 | Upgrade
|
| Cash & Short-Term Investments | 3,489 | 3,518 | 4,751 | 4,244 | 3,791 | 2,119 | Upgrade
|
| Cash Growth | -29.77% | -25.95% | 11.95% | 11.95% | 78.94% | 8.63% | Upgrade
|
| Accounts Receivable | 2,737 | 1,966 | 2,131 | 3,348 | 3,796 | 5,198 | Upgrade
|
| Other Receivables | 35.79 | 23.06 | 11.49 | 8.98 | 9.47 | 421.43 | Upgrade
|
| Receivables | 2,772 | 1,989 | 2,142 | 3,357 | 3,805 | 5,619 | Upgrade
|
| Inventory | 1,429 | 1,712 | 1,748 | 1,532 | 1,548 | 1,354 | Upgrade
|
| Other Current Assets | 109.31 | 91.72 | 91.43 | 127.08 | 105 | 145.92 | Upgrade
|
| Total Current Assets | 7,800 | 7,311 | 8,733 | 9,260 | 9,249 | 9,237 | Upgrade
|
| Property, Plant & Equipment | 3,502 | 3,648 | 3,769 | 3,883 | 4,088 | 3,881 | Upgrade
|
| Long-Term Investments | 1,469 | 1,821 | 2,054 | 1,511 | 1,229 | 1,535 | Upgrade
|
| Goodwill | - | - | 15.88 | 15.88 | 167.08 | 15.88 | Upgrade
|
| Other Intangible Assets | 779.33 | 604.17 | 573.64 | 459.43 | 474.54 | 361.4 | Upgrade
|
| Long-Term Deferred Tax Assets | 49.18 | 53.17 | 50 | 88.29 | 60.79 | 42.82 | Upgrade
|
| Long-Term Deferred Charges | 1,306 | 1,466 | 1,476 | 1,157 | 1,193 | 1,412 | Upgrade
|
| Other Long-Term Assets | 52.18 | 72.54 | 43.14 | 102.08 | 79.68 | 8.45 | Upgrade
|
| Total Assets | 14,957 | 14,976 | 16,714 | 16,477 | 16,542 | 16,494 | Upgrade
|
| Accounts Payable | 329.26 | 606.81 | 572.73 | 887.77 | 728.58 | 572.52 | Upgrade
|
| Accrued Expenses | 240.01 | 171.05 | 178.38 | 242.79 | 213.15 | 200.28 | Upgrade
|
| Short-Term Debt | 464.76 | 710.95 | 814.63 | 201.77 | 188.79 | 638.73 | Upgrade
|
| Current Portion of Long-Term Debt | 166.3 | 586.83 | 462.74 | 475.21 | 343.33 | 1,137 | Upgrade
|
| Current Portion of Leases | - | 47.84 | 58.54 | 53.98 | 55.67 | - | Upgrade
|
| Current Income Taxes Payable | 138.78 | 57.78 | 18.04 | 84.62 | 108.09 | 34.6 | Upgrade
|
| Current Unearned Revenue | 52.87 | 69.85 | 91.62 | 92.35 | 68.33 | 26.82 | Upgrade
|
| Other Current Liabilities | 647.23 | 98.58 | 172.88 | 108.72 | 149.12 | 221.86 | Upgrade
|
| Total Current Liabilities | 2,039 | 2,350 | 2,370 | 2,147 | 1,855 | 2,832 | Upgrade
|
| Long-Term Debt | 178.84 | 253.76 | 1,414 | 1,376 | 1,034 | 1,020 | Upgrade
|
| Long-Term Leases | 47.13 | 67.97 | 81.52 | 75.31 | 81.63 | - | Upgrade
|
| Long-Term Unearned Revenue | 191.66 | 193.29 | 159.02 | 177.79 | 214.57 | 234.56 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.4 | 0.4 | 0.11 | 22.87 | 42.18 | 22.55 | Upgrade
|
| Total Liabilities | 2,457 | 2,865 | 4,024 | 3,799 | 3,228 | 4,109 | Upgrade
|
| Common Stock | 1,494 | 1,494 | 1,500 | 1,500 | 1,513 | 1,513 | Upgrade
|
| Additional Paid-In Capital | 472.37 | 458.96 | 958.08 | 1,457 | 1,530 | 2,321 | Upgrade
|
| Retained Earnings | 10,270 | 9,898 | 9,929 | 9,351 | 10,222 | 8,359 | Upgrade
|
| Treasury Stock | - | - | -105.98 | -105.98 | -251.29 | -194.86 | Upgrade
|
| Comprehensive Income & Other | 68.04 | 52.22 | 88 | 211.58 | -32.19 | -25.1 | Upgrade
|
| Total Common Equity | 12,304 | 11,903 | 12,368 | 12,412 | 12,981 | 11,972 | Upgrade
|
| Minority Interest | 195.66 | 207.86 | 321.59 | 265.12 | 332.56 | 411.77 | Upgrade
|
| Shareholders' Equity | 12,500 | 12,111 | 12,690 | 12,678 | 13,314 | 12,384 | Upgrade
|
| Total Liabilities & Equity | 14,957 | 14,976 | 16,714 | 16,477 | 16,542 | 16,494 | Upgrade
|
| Total Debt | 857.03 | 1,667 | 2,831 | 2,182 | 1,704 | 2,796 | Upgrade
|
| Net Cash (Debt) | 2,632 | 1,851 | 1,920 | 2,062 | 2,088 | -677.47 | Upgrade
|
| Net Cash Growth | -5.91% | -3.59% | -6.89% | -1.23% | - | - | Upgrade
|
| Net Cash Per Share | 1.77 | 1.24 | 1.29 | 1.40 | 1.39 | -0.45 | Upgrade
|
| Filing Date Shares Outstanding | 1,494 | 1,494 | 1,494 | 1,494 | 1,499 | 1,503 | Upgrade
|
| Total Common Shares Outstanding | 1,494 | 1,494 | 1,494 | 1,494 | 1,499 | 1,503 | Upgrade
|
| Working Capital | 5,760 | 4,961 | 6,363 | 7,113 | 7,394 | 6,406 | Upgrade
|
| Book Value Per Share | 8.24 | 7.97 | 8.28 | 8.31 | 8.66 | 7.97 | Upgrade
|
| Tangible Book Value | 11,525 | 11,299 | 11,779 | 11,937 | 12,340 | 11,595 | Upgrade
|
| Tangible Book Value Per Share | 7.71 | 7.56 | 7.88 | 7.99 | 8.23 | 7.71 | Upgrade
|
| Buildings | - | 3,517 | 3,505 | 3,490 | 3,398 | 3,239 | Upgrade
|
| Machinery | - | 3,763 | 3,625 | 3,472 | 3,340 | 2,974 | Upgrade
|
| Construction In Progress | - | 221.76 | 153.87 | 102.96 | 167.85 | 400.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.